Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 23, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$27.1B
sum of reported positions
Reported positions
665
Changes vs prior quarter
615
56 new · 37 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 351 measured positions in 8 quarters, the typical new or larger position finished −3.4 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 503 funds with a result: −2.1 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
1,467 institutions report a stake.
Also among the 20 largest: Investor AB, Capital International Investors, Capital World Investors
6,246 institutions report a stake.
Also among the 20 largest: Capital World Investors, Berkshire Hathaway, Capital Research Global Investors
| Company | Shares | Value | Weight | Of company |
|---|---|---|---|---|
| $1.49B | 5.5% | — | ||
| $1.42B | 5.2% | 0.03% | ||
| $1.38B | 5.1% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
In its latest 13F, with holdings as of Jun 30, 2026 (Q2 2026), Rathbones Group PLC reported 665 positions worth $27.1B. The largest: Astrazeneca (AZN), 5.5%; Alphabet (GOOGL), 5.2%; Microsoft (MSFT), 5.1%; NVIDIA (NVDA), 4.7%; Amazon (AMZN), 4.5%. The five largest make up 25% of the reported portfolio.
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $48.4B | $27.1B |
| Positions | 646 | 665 |
| Biggest line | — | Astrazeneca 6% |
6,198 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors, Capital World Investors, Capital International Investors
5,947 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors
6,117 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors, Capital World Investors
4,555 institutions report a stake.
Also among the 20 largest: TCI Fund Management Ltd, Capital World Investors, Capital International Investors
| 0.05% |
| $1.28B | 4.7% | 0.03% |
| $1.22B | 4.5% | 0.05% |
| $1.08B | 4.0% | — |
| $989M | 3.6% | 0.02% |
| $901M | 3.3% | 0.10% |
| $559M | 2.1% | 0.13% |
| $537M | 2.0% | 0.05% |
| $525M | 1.9% | 0.00% |
| $523M | 1.9% | 0.01% |
| $504M | 1.9% | 0.27% |
| $492M | 1.8% | 0.14% |
| $483M | 1.8% | — |
| $448M | 1.7% | 0.02% |
| $391M | 1.4% | 0.03% |
| $373M | 1.4% | 0.13% |
| $316M | 1.2% | 0.44% |
| $289M | 1.1% | 0.36% |
| $283M | 1.0% | 0.12% |
| $279M | 1.0% | 0.10% |
| $279M | 1.0% | 0.18% |
| $252M | 0.9% | 0.15% |
| $250M | 0.9% | 0.06% |
Orion Digital (ORIO)
21K → 10K shares (−50%)
BEYOND MEAT INC USD0.0001 Common Stock
23K → 11K shares (−51%)
SRX HEALTH SOLUTIONS INC USD0.001 Com Stk (P-R Split)
40K → 20K shares (−50%)
Broadridge Financial Solutions (BR)
805K shares in Q1 2026
BioLife Solutions, Inc. (BLFS)
154K shares in Q1 2026
THOMSON REUTERS CORP NPV Com Stk (Post Rev Split)
141K shares in Q1 2026
CARNIVAL CORP USD0.001 Common (Paired Stock)
111K shares in Q1 2026
Iamgold (IAG)
84K shares in Q1 2026
Ecopetrol (EC)
65K shares in Q1 2026
Callaway Golf Company (CALY)
43K shares in Q1 2026
Avino Silver & Gold Mines (ASM)
42K shares in Q1 2026
PETROLEO BRASILEIRO SA Spon ADR Rep 4 Pref Shares
41K shares in Q1 2026
General Mills (GIS)
41K shares in Q1 2026
Harmony Gold Mining (HMY)
37K shares in Q1 2026
Drdgold (DRD)
33K shares in Q1 2026
FIRST TRUST SMID Cap Rising Div Achvrs ETF
33K shares in Q1 2026
Accendra Health Inc (ACH)
31K shares in Q1 2026
BROOKFIELD BUSINESS PARTNERS Unit Ltd Partnership
27K shares in Q1 2026
Ondas (ONDS)
27K shares in Q1 2026
Ares Capital (ARCC)
25K shares in Q1 2026
New Found Gold (NFGC)
23K shares in Q1 2026
KALVISTA PHARMACEUTICALS INC USD0.001 Common Stock
22K shares in Q1 2026
ETF SERIES SOLUTIONS US Global Jets ETF
19K shares in Q1 2026
Yum China Holdings (YUMC)
17K shares in Q1 2026
Zimmer Biomet (ZBH)
17K shares in Q1 2026
Astrazeneca (AZN): $1.49B, or 5.5% of the portfolio reported for Q2 2026.
Between its last two 13F reports, Rathbones Group PLC opened 56 new positions, added to 16, trimmed 506 and sold out of 37. The comparison is in share counts, so a price move alone does not count as buying or selling.
Its 13F for Q2 2026 adds up to $27.1B. That is not the whole firm: a 13F lists only US-listed shares and some options held at the end of the quarter, and leaves out cash, bonds, short positions and foreign holdings.
The report for Q2 2026 was filed on Jul 23, 2026. A manager has 45 days after the end of each quarter to file, so the holdings are always several weeks old when they become public.
On 351 positions it reported as new or larger over 8 quarters, the typical one finished −3.4 points against the S&P 500 after 90 days, and 42% finished ahead of it. Measured from the day each filing became public; history, not a forecast.
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.